The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Budzinskaia M.V.

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

Mazurina N.K.

Posterior segment eye surgery and diagnostics center LLC, 2-aya Vladimirskaya St., Moscow, Russian Federation, 111123

Egorov A.E.

Pirogov Russian National Research Medical University, 1 Ostrovityanova St., Moscow, Russian Federation 117997

Kuroedov A.V.

Pirogov Russian National Research Medical University, 1 Ostrovityanova St., Moscow, Russian Federation 117997;
Mandryka Clinical Research and Training Medical Center, 8A Bol'shaya Olen'ya St., Moscow, Russian Federation, 107014

Loskutov I.A.

Scientific Clinical Center of JSC Russian Railways, 20 Chasovaya St., Russian Federation, 125315

Pliukhova A.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Razik S.

Medical diagnostic center «Olimp» LLC, 77 Udal’tsova St., Moscow, Russian Federation, 119454

Ryabtseva A.A.

Vladimirsky Moscow Regional Research Clinical Institute, Moscow

Simonova S.V.

S.P. Botkin State Clinical Hospital, Branch №1, Moscow Department of Public Health, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001

Retinal vein occlusion management algorithm. Part 1. Classification, diagnosis, and acute-stage treatment

Authors:

Budzinskaia M.V., Mazurina N.K., Egorov A.E., Kuroedov A.V., Loskutov I.A., Pliukhova A.A., Razik S., Ryabtseva A.A., Simonova S.V.

More about the authors

Journal: Russian Annals of Ophthalmology. 2015;131(6): 51‑56

DOI: 10.17116/oftalma2015131651-56

Read: 1472 times

Download PDF (RU)
Contact the author
Table of contents

RETINAL VEIN OCCLUSION MANAGEMENT ALGORITHM. PART 1. CLASSIFICATION, DIAGNOSIS, AND ACUTE-STAGE TREATMENT
RETINAL VEIN OCCLUSION MANAGEMENT ALGORITHM. PART 1. CLASSIFICATION, DIAGNOSIS, AND ACUTE-STAGE TREATMENT

To cite this article:

Budzinskaia MV, Mazurina NK, Egorov AE, et al. . Retinal vein occlusion management algorithm. Part 1. Classification, diagnosis, and acute-stage treatment. Russian Annals of Ophthalmology. 2015;131(6):51‑56. (In Russ.)
https://doi.org/10.17116/oftalma2015131651-56

Подписка 2025-2 (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Prevalence of diabetic reti­nopathy asse­ssed using two-field mydriatic fundus photography. Russian Annals of Ophthalmology. 2024;(4):60-67
Biosimilars of rani­bizumab in reti­nal diseases: new possibilities in ophthalmology. Russian Annals of Ophthalmology. 2025;(2):106-116
Fore­nsic characteristic of sudden death cases in subjects with meta­bolic syndrome. Fore­nsic Medi­cal Expe­rtise. 2024;(4):54-57
Fore­nsic asse­ssment of meteorological conditions as risk factors of sudden death from arte­rial hype­rtension. Fore­nsic Medi­cal Expe­rtise. 2024;(4):65-68
Method of manual-physical correction in the treatment of hype­rtensive disease and normalization of psychoneurological status in patients with dege­nerative-dystrophic processes of the musculoskeletal system. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(4):16-22
«Selfish brain» theory: modern concept and practical use. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):66-73
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43
Risk factors and adve­rse outcomes of cardiovascular diseases in people with high normal blood pressure of the Ryazan region. (5-year prospective follow-up). Russian Journal of Preventive Medi­cine. 2025;(2):31-37
Diagnostics of hype­rtensive diso­rders in cardio-obstetrics: current state-of-affairs. Russian Journal of Human Reproduction. 2025;(1):63-77
Study of the levo­carnitine effi­cacy for the treatment of mode­rate cognitive impairment in patients with hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(4):45-50

Considering an upward global trend in cardiovascular disease rates, retinal vein occlusion (RVO) in particular, development of therapeutic guidelines is a pressing issue in ophthalmology. Risk factors for RVO include hypertension, atherosclerosis, diabetes mellitus, blood disorders, inflammatory disorders, and prescription drug use. Three stages of RVO have been identified. By location, the entity can be divided into three big groups: central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), and hemicentral retinal vein occlusion (HCRVO), each being either ischemic or nonischemic. Functional prognosis is better in nonischemic occlusions. Patient management comprises acute-stage treatment (anticoagulants, fibrinolytic agents, and hemodilution) and struggling with ocular complications (intravitreal injections and laser coagulation). It is essential that primary assessment and follow-up of patients at any stage of RVO include optical coherence tomography and fluorescent angiography.

Keywords:

eye
retina
hypertension
central retinal vein occlusion
branch retinal vein occlusion
macular edema
laser coagulation
ranibizumab
Ozurdex
aflibercept

Authors:

Budzinskaia M.V.

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

Mazurina N.K.

Posterior segment eye surgery and diagnostics center LLC, 2-aya Vladimirskaya St., Moscow, Russian Federation, 111123

Egorov A.E.

Pirogov Russian National Research Medical University, 1 Ostrovityanova St., Moscow, Russian Federation 117997

Kuroedov A.V.

Pirogov Russian National Research Medical University, 1 Ostrovityanova St., Moscow, Russian Federation 117997;
Mandryka Clinical Research and Training Medical Center, 8A Bol'shaya Olen'ya St., Moscow, Russian Federation, 107014

Loskutov I.A.

Scientific Clinical Center of JSC Russian Railways, 20 Chasovaya St., Russian Federation, 125315

Pliukhova A.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Razik S.

Medical diagnostic center «Olimp» LLC, 77 Udal’tsova St., Moscow, Russian Federation, 119454

Ryabtseva A.A.

Vladimirsky Moscow Regional Research Clinical Institute, Moscow

Simonova S.V.

S.P. Botkin State Clinical Hospital, Branch №1, Moscow Department of Public Health, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001

List of references:

  1. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. International Eye Disease Consortium. Ophthalmology. 2010;117(2):313-319. doi:10.1016/j.ophtha.2009.07.017
  2. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Archives of Ophthalmology. 1982;100(7):1132-1140. doi:10.1001/archopht.1982.01030040110020
  3. Duker JS, Brown GC. Anterior location of the crossing artery in branch retinal vein obstruction. Archives of Ophthalmology. 1989;107(7):998-1000. doi:10.1001/archopht.1989.01070020060029
  4. Libman E, Shahova E. Sostojanie i dinamika slepoty i invalidnosti vsledstvie patologii organa zrenija v Rossii. VII S#ezd oftal'mologov Rossii. Moskva, 2000, Tez. dokl. Chast' 2. S. 209-2143. (In Russ.)
  5. Zhao J, Sastry SM, Sperduto RD, Chew EY, Remaley NA. Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology. 1993;100(3):423-428. doi:10.1016/S0161-6420(93)31633-7
  6. Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology. 1999;106(11):2054-2062. doi:10.1016/s0161-6420(99)90483-9
  7. Haymore JG, Mejico LJ. Retinal vascular occlusion syndromes. International Ophthalmology Clinics. 2009;49:63-79. doi:10.1097/iio.0b013e3181a8db88
  8. Feman SS, Stein RS. Waldenstroms macroglobulinemia, a hyperviscosity manifestation of venous stasis retinopathy. International Ophthalmology. 1981;4(1-2):107-112. doi:10.1007/BF00139584
  9. Brunette I, Boghen D. Central retinal vein occlusion complicating spontaneous carotid-cavernous fistula. Case report. Archives of Ophthalmology. 1987;105(4):464-465. doi:10.1001/archopht.1987.01060040034017
  10. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371-422.
  11. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Progress in Retinal and Eye Research. 2005;24(4):493-519. doi:10.1016/j.preteyeres.2004.12.001
  12. Hayreh SS, Patricia A. Podhajsky, Bridget Zimmerman. Natural History of Visual Outcome in Central Retinal Vein Occlusion. Ophthalmology. 2011;118(1):119-133. doi:10.1016/j.ophtha.2010.04.019
  13. Hayreh SS, Zimmerman MB. Ocular neovascularization associated with central and hemicentral retinal vein occlusion. Retina. 2012;32(8):1553-1565. doi:10.1097/iae.0b013e318246912c
  14. Central Vein Occlusion Study Group. Baseline and early natural history report: the Central Vein Occlusion Study. Archives of Ophthalmology. 1993;111(8):1087-1095. doi:10.1001/archopht.1993.01090080083022
  15. McIntosh RL, Rogers SL, Lyndell Lim, Ning Cheung, Jie Jin Wang, Paul Mitchell, Kowalski JW, Nguyen HP, Tien Yin Wong. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117(6):1113-1123. doi:10.1016/j.ophtha.2010.01.060
  16. Rogers SL, McIntosh RL, Lyndell Lim, Paul Mitchell, Ning Cheung, Kowalski JW, Nguyen HP, Jie Jin Wang, Tien Yin Wong. Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic Review. Ophthalmology. 2010;117(6):1094-1101. doi:10.1016/j.ophtha.2010.01.058
  17. Brown DM, Heier JS, Clark WL, et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-Year Results From the Phase 3 COPERNICUS Study. American Journal of Ophthalmology. 2013;155(3):429-437. doi:10.1016/j.ajo.2012.09.026
  18. Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Archives of Ophthalmology.1996;114(5):545-554. doi:10.1001/archopht.1996.01100130537006
  19. Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. American Journal of Ophthalmology. 1993;116(3):286-296. doi:10.1016/S0002-9394(14)71345-5
  20. Wang S, Xu L, Jonas JB, Wong TY, Cui T, Li Y, Wang YX, You QS, Yang H, Sun C. Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study. Ophthalmology. 2009;116(12):2373-2380. doi:10.1016/j.ophtha.2009.05.041
  21. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Archives of Ophthalmology. 1996;114(10):1243-1247. doi:10.1001/archopht.1996.01100140443012
  22. Central Vein Occlusion Study Group: A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N Report. Ophthalmology. 1995;102:1434-1444. doi:10.1016/S0161-6420(95)30848-2
  23. Campochiaro PA, Raafay Sophie, Joel Pearlman, Brown DM, Boyer DS, Heier JS, Marcus DM, Leonard Feiner, Arun Patel, for the RETAIN Study Group. Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab. The RETAIN Study. Ophthalmology. 2014;12(1):209-219. doi:10.1016/j.ophtha.2013.08.038
  24. Hattenbach LO, Wellermann G, Steinkamp GW, Scharrer I, Koch FH, Ohrloff C. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica. 1999;213(6):360-366. doi:10.1159/000027455
  25. Coscas G, Loewenstein A, Augustin A, Bandello F, Battaglia Parodi M, Lanzetta P, Monés J, de Smet M, Soubrane G, Staurenghi G. Management of Retinal Vein Occlusion - Consensus Document. Ophthalmologica. 2011;226(1):4-28. doi:10.1159/000327391
  26. Hansen LL, Wiek J, Schade M, Müller-Stolzenburg N, Wiederholt M. Effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and nonischaemic central retinal vein occlusion. Ophthalmologica. 1989;199(2-3):90-99. doi:10.1159/000310023
  27. Hansen LL, Wiek J, Wiederholt M. A randomized prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. British Journal of Ophthalmology. 1989;73(11):895-899. doi:10.1136/bjo.73.11.895
  28. Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald KJ, Reim M. Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology. 1994;232(1):33-39. doi:10.1007/bf00176435
  29. Hattenbach LO, Wellermann G, Steinkamp GW, Scharrer I, Koch FH, Ohrloff C. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica. 1999;213(6):360-366. doi:10.1159/000027455
  30. Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas G, Soubrane G. Effect of isovolemic hemodilution in central retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology. 2001;239(12):909-914. doi:10.1007/s00417-001-0388-0
  31. Glacet-Bernard A, Atassi M, Fardeau C, Romanet JP, Tonini M, Conrath J, Denis P, Mauget-Faÿsse M, Coscas G, Soubrane G, Souied E. Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2010;249(4)505-512. doi:10.1007/s00417-010-1532-5
  32. Chiquet C, Tonini M, Drillat P, Gaudry VV, Romanet JP, Geiser MH. Choroidal blood flow after isovolemic hemodilution in an eye with retinal vein occlusion and the contralateral healthy eye. Retina. 2010;30(2):275-280. doi:10.1097/iae.0b013e3181b85f18
  33. Glacet-Bernard A, les Jardins GL, Lasry S, Coscas G, Soubrane G, Souied E, Housset B. Obstructive sleep apnea among patients with retinal vein occlusion. Archives of Ophthalmology. 2010;128(12):1533-1538. doi:10.1001/archophthalmol.2010.272
  34. Kreutzer TC, Wolf A, Dirisamer M, Strauss RW, Foerster P, Feltgen N, Pielen A, Hattenbach LO, Kampik A, Priglinger SG Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial. Ophthalmologica. 2015;233(1):8-17. doi:10.1159/000369566
  35. Arevalo JF, Garcia RA, Wu L, Rodriguez FJ, Dalma-Weiszhausz J, Quiroz-Mercado H, Morales-Canton V, Roca JA, Berrocal MH, Graue-Wiechers F, Robledo V, Pan American Collaborative Retina Study Group: Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES). Retina. 2008;28(8):1044-1052. doi:10.1097/IAE.0b013e3181744153
  36. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108(12):2249-2257. doi:10.1016/s0161-6420(01)00875-2
  37. Avci R, Inan ÜÜ, Kaderli B. Arteriovenous crossing sheathotomy for branch retinal vein occlusion. Eye. 2010;22(1):120-127. doi:10.1038/sj.eye.6702633

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.